A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology.

With age comes wisdom, we’re told. But retaining the ability to recall the whereabouts of your glasses? Forget it – or so we're told

On Friday, a prominent biographer of President Donald Trump took to social media to warn that the commander-in-chief had “invaded Canada.”

The agency had initially refused to even review the application but reversed course after a public outcry.

The BBC has confirmed Blankety Blank, Celebrity Mastermind and Live at the Apollo will not be returning. Mastermind presented by Clive Myrie will continue and both Celebrity Mastermind and Live at the...

Hey 👋 LifuX is a community for funny animals, wholesome moments, and everyday chaos. I share videos, photos, and stories designed to make your day a little brighter. Your support helps me create more

New powers criminalise face coverings at demonstrations and ban protests outside politicians' homes

Sequencing-based wastewater surveillance is emerging as an important tool in pathogen-agnostic threat detection, potentially enabling early identification before capture through clinical surveillance ...

New evidence shows COVID-19 can cause lasting cardiovascular damage, from accelerated vascular ageing to plaque progression and post-acute heart symptoms. Learn what global studies reveal about the lo...

As millions of soccer fans pack FIFA World Cup venues, public health scientists created a wastewater monitoring network to forecast potential disease threats—from measles to Ebola

Explore our work in research, public health and education at the Doherty Institute.

These large and highly-anticipated trials found no reduction in hospitalization or death—and reveal how much the risk of Covid-19 has fallen.

EXCLUSIVE The smash hit detective series starring David Mitchell and Anna Maxwell Martin has been recommissioned for a third series by the BBC - ahead of the second series which is expected to air lat...